Published by Josh White on 26th June 2023
(Sharecast News) - GSK announced two significant advancements on Monday, with the approval of an updated indication for Shingrix in Japan, as well as a positive opinion from the European Medicines Agency for daprodustat.
URL: http://www.digitallook.com/dl/news/story/33596282/...